Prelude Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-208,861
| Closed | -$10.8M | – | 1801 |
|
|
2022
Q3 | $10.8M | Buy |
208,861
+191,661
| +1,114% | +$9.9M | 0.39% | 25 |
|
|
2022
Q2 | $426K | Buy |
+17,200
| New | +$426K | 0.01% | 748 |
|
|
2022
Q1 | – | Sell |
-18,500
| Closed | -$674K | – | 2151 |
|
|
2021
Q4 | $674K | Buy |
+18,500
| New | +$674K | 0.02% | 642 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1866 |
|
|
2019
Q3 | – | Sell |
-571
| Closed | -$5K | – | 1724 |
|
|
2019
Q2 | $5K | Buy |
+571
| New | +$5K | ﹤0.01% | 1133 |
|
|
2019
Q1 | – | Sell |
-1,076
| Closed | -$12K | – | 1867 |
|
|
2018
Q4 | $12K | Hold |
1,076
| – | – | ﹤0.01% | 1010 |
|
|
2018
Q3 | $14K | Buy |
+1,076
| New | +$14K | ﹤0.01% | 1042 |
|
|
2018
Q2 | – | Sell |
-983
| Closed | -$13K | – | 1756 |
|
|
2018
Q1 | $13K | Buy |
+983
| New | +$13K | ﹤0.01% | 1164 |
|
|
2017
Q4 | – | Sell |
-500
| Closed | -$4K | – | 1678 |
|
|
2017
Q3 | $4K | Sell |
500
-1,100
| -69% | -$8.8K | ﹤0.01% | 1397 |
|
|
2017
Q2 | $15K | Buy |
1,600
+1,400
| +700% | +$13.1K | ﹤0.01% | 1210 |
|
|
2017
Q1 | $1K | Sell |
200
-500
| -71% | -$2.5K | ﹤0.01% | 1398 |
|
|
2016
Q4 | $5K | Buy |
700
+171
| +32% | +$1.22K | ﹤0.01% | 1393 |
|
|
2016
Q3 | $3K | Buy |
+529
| New | +$3K | ﹤0.01% | 1446 |
|
|
2013
Q4 | – | Sell |
-1,820
| Closed | -$10K | – | 1858 |
|
|
2013
Q3 | $10K | Buy |
+1,820
| New | +$10K | ﹤0.01% | 1173 |
|